|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2011-3-30
|
|
pubmed:abstractText |
To assess the efficacy of salvage radiation therapy (RT) in patients with recurrent/refractory primary or secondary central nervous system lymphoma (CNSL) after initial methotrexate (MTX)-based chemotherapy and to identify factors associated with treatment outcome.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1569-8041
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
© The Author 2010. Published by Oxford University Press on behalf of the European Society for Medical Oncology.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
979-84
|
|
pubmed:meshHeading |
pubmed-meshheading:20935059-Adult,
pubmed-meshheading:20935059-Aged,
pubmed-meshheading:20935059-Aged, 80 and over,
pubmed-meshheading:20935059-Central Nervous System Neoplasms,
pubmed-meshheading:20935059-Disease-Free Survival,
pubmed-meshheading:20935059-Female,
pubmed-meshheading:20935059-Humans,
pubmed-meshheading:20935059-Lymphoma,
pubmed-meshheading:20935059-Male,
pubmed-meshheading:20935059-Methotrexate,
pubmed-meshheading:20935059-Recurrence,
pubmed-meshheading:20935059-Retrospective Studies,
pubmed-meshheading:20935059-Salvage Therapy,
pubmed-meshheading:20935059-Treatment Outcome
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Salvage radiotherapy in patients with recurrent or refractory primary or secondary central nervous system lymphoma after methotrexate-based chemotherapy.
|
|
pubmed:affiliation |
Department of Radiation Oncology, Brigham & Women's Hospital and Dana-Farber Cancer Institute, Boston, MA 02115, USA.
|
|
pubmed:publicationType |
Journal Article
|
